{
    "nctId": "NCT03594578",
    "briefTitle": "Prospective Thinking in Hormone-Responsive Breast Cancer",
    "officialTitle": "Effects of a Prospective Thinking Intervention on Delay Discounting in Patients With Hormone-Responsive Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Hormone Receptor Positive Malignant Neoplasm of Breast",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "BASIC_SCIENCE",
    "enrollmentCount": 89,
    "primaryOutcomeMeasure": "Delay discounting (monetary)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age 18-80 years\n* Female\n* Must have a history of hormone responsive breast cancer treated with curative intent and have been recommended/prescribed adjuvant HT (tamoxifen, anastrozole, letrozole or exemestane) by their physician.\n\nExclusion Criteria:\n\n* Recurrent breast cancer\n* Adjuvant hormone therapy is no longer medically appropriate/advisable\n* Incapable/ without capacity to provide personal consent\n* Suffers from cognitive or physical impairments which interfere with medication self- administration and/or participation in episodic thinking\n* Receiving HT for metastatic disease",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}